The paper discusses quality issues found in market samples of mineral medicine Calamina and calcined Calamina and proposes solutions based on analysis results.
XRD analysis and tests from the Chinese Pharmacopoeia confirmed the authenticity of samples, while various spectrometry methods identified impurity and harmful elements present.
Key findings indicate a prevalence of fake products, inconsistency with pharmacopoeia standards, and high levels of harmful elements like lead and cadmium, leading to recommended actions for better regulation and quality control.